Abstract
Epoxycarotenoids form a family of about 200 natural pigments present in photosynthetic organisms, fungi, and animal and human tissues. Numerous studies have evidenced that they exert strong antiproliferative, cytotoxic and proapoptotic activities in cancer cells grown in vitro, and that some of them are resorbed per os, suggesting that they may prevent cancer in vivo. This paper presents a comprehensive description of epoxycarotenoids reported up to 2011 (chemical structure, natural sources, human and animal absorption studies, physiological metabolites) and reviews their biological activity in cancer cells grown in vitro (antiproliferative, cytotoxic and pro-apoptotic activities; molecular and pharmacological targets, ability to reverse multidrug resistance, anti-angiogenic activity).
Keywords: Epoxycarotenoid, carotenoid, epoxyxanthophyll, pigment, cancer, MDR, photosynthetic organisms, antiproliferative, cytotoxic, pro-apoptotic.
Current Bioactive Compounds
Title:Epoxycarotenoids and Cancer. Review
Volume: 8 Issue: 2
Author(s): Anne-Laure Gagez, Valerie Thiery, Virginie Pasquet, Jean-Paul Cadoret and Laurent Picot
Affiliation:
Keywords: Epoxycarotenoid, carotenoid, epoxyxanthophyll, pigment, cancer, MDR, photosynthetic organisms, antiproliferative, cytotoxic, pro-apoptotic.
Abstract: Epoxycarotenoids form a family of about 200 natural pigments present in photosynthetic organisms, fungi, and animal and human tissues. Numerous studies have evidenced that they exert strong antiproliferative, cytotoxic and proapoptotic activities in cancer cells grown in vitro, and that some of them are resorbed per os, suggesting that they may prevent cancer in vivo. This paper presents a comprehensive description of epoxycarotenoids reported up to 2011 (chemical structure, natural sources, human and animal absorption studies, physiological metabolites) and reviews their biological activity in cancer cells grown in vitro (antiproliferative, cytotoxic and pro-apoptotic activities; molecular and pharmacological targets, ability to reverse multidrug resistance, anti-angiogenic activity).
Export Options
About this article
Cite this article as:
Gagez Anne-Laure, Thiery Valerie, Pasquet Virginie, Cadoret Jean-Paul and Picot Laurent, Epoxycarotenoids and Cancer. Review, Current Bioactive Compounds 2012; 8 (2) . https://dx.doi.org/10.2174/157340712801784787
DOI https://dx.doi.org/10.2174/157340712801784787 |
Print ISSN 1573-4072 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-6646 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
Tobacco, Inflammation, and Respiratory Tract Cancer
Current Pharmaceutical Design New Developments in Matrices for Ocular Surface Reconstruction
Current Tissue Engineering (Discontinued) Current Perspectives on the Therapeutic Utility of VR1 Antagonists
Current Medicinal Chemistry Molecular Mechanisms and Therapeutic Application of NSAIDs and Derived Compounds in Alzheimers Disease
Current Alzheimer Research A Review of Natural and Modified Betulinic, Ursolic and Echinocystic Acid Derivatives as Potential Antitumor and Anti-HIV Agents
Mini-Reviews in Medicinal Chemistry Cellular and Molecular Pathways that Lead to Progression and Regression of Renal Fibrogenesis
Current Molecular Medicine DNMT3B Promoter Polymorphisms and Risk of Late Onset Alzheimer’s Disease
Current Alzheimer Research Neurokinin Receptors as Potential Targets in Breast Cancer Treatment
Current Drug Discovery Technologies Therapeutic Potential of Group III Metabotropic Glutamate Receptors
Current Medicinal Chemistry Dasabuvir: A Non-Nucleoside Inhibitor of NS5B for the Treatment of Hepatitis C Virus Infection
Reviews on Recent Clinical Trials De Novo Malignancies After Organ Transplantation: Focus on Viral Infections
Current Molecular Medicine Editorial [Hot Topic Lipohepatotoxicity and Nonalcoholic Steatohepatitis (NASH)-Like Metabolic Disorders (Guest Editor: Mustapha Cherkaoui-Malki)]
Current Drug Metabolism Newly-onset Autoimmune Diabetes Mellitus Triggered by COVID 19 Infection: A Case-based Review
Endocrine, Metabolic & Immune Disorders - Drug Targets Antioxidant Therapeutic Approaches Toward Amelioration of the Pulmonary Pathophysiological Damaging Effects of Ionizing Irradiation
Current Respiratory Medicine Reviews Biological Markers of Alzheimers Disease and Mild Cognitive Impairment
Current Alzheimer Research Anti-Inflammatory Therapy in Uveitis
Recent Patents on Inflammation & Allergy Drug Discovery New Frontiers in Regenerative Medicine in Cardiology: The Potential of Wharton’s Jelly Mesenchymal Stem Cells
Current Stem Cell Research & Therapy Anti-Apoptotic Genes in the Survival of Monocytic Cells During Infection
Current Genomics Stevens-Johnson Syndrome and Toxic Epidermal Necrolysis: Medical and Societal Impact
Current Immunology Reviews (Discontinued) Experimental Methods and Transport Models for Drug Delivery Across the Blood-Brain Barrier
Current Pharmaceutical Biotechnology